Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
06-2013 | 05-2013 | 03-2013 | 02-2013 | |
Sales | 6 | 6 | 0 | 0 |
Cost of Goods | 2 | 2 | N/A | 0 |
Gross Profit | 4 | 4 | N/A | 0 |
Operating Expenses | 1,932 | 1,930 | 0 | 0 |
Operating Income | -1,926 | -1,926 | N/A | 0 |
Interest Expense | 1 | 0 | 0 | 0 |
Other Income | 7 | 6 | 0 | 0 |
Pre-tax Income | -1,920 | -1,920 | 0 | 0 |
Net Income Continuous | -1,925 | -1,925 | -1,957 | 0 |
Net Income | $-1,925 | $-1,925 | $-1,956 | $0 |
EPS Basic Total Ops | -14.40 | -0.30 | -14.40 | N/A |
EPS Basic Continuous Ops | -12.62 | -0.26 | -12.91 | N/A |
EPS Diluted Total Ops | -14.40 | -0.30 | -14.40 | N/A |
EPS Diluted Continuous Ops | -12.62 | -0.26 | -12.91 | N/A |
EBITDA(a) | $-1,766 | $-1,766 | $N/A | $0 |